New insights into pain relief drugs

Photo by Jonathan Lindberg for Coast Guard

(Medical Xpress)—Scientists from the Research School of Biology have opened the door to a new world of pain treatments with their discovery of the exact way that pain relief drugs, such as anaesthetics, work on the body.

Dr Ben Corry and Lewis Martin developed a detailed computer model that revealed for the first time how benzocaine, a local anaesthetic, and phenytoin, an anti-epilepsy , enter into and prevent the signals being transmitted to the brain.

"By understanding how the current range of drugs work we can best design the next generation, to better treat conditions such as , epilepsy and cardiac arrhythmia," said Dr Corry.

The precise knowledge of how the drug molecules attach to proteins in the nerve cell give a springboard for redesigning drugs without the side-effects that current drugs bring with them.

Their work, from the Research School of Biology at ANU is published in the latest edition of PLOS Computational Biology.

Local anaesthetics were first inspired by cocaine and have been in use for more than 100 years, but the exact mechanism has not been understood until now.

The pair used more than three million CPU hours on the National Computational Infrastructure's supercomputer to simulate the drug's route into the nerve cell.

This video is not supported by your browser at this time.

Pain signals are transmitted to the brain when proteins that act as tiny gateways in nerve cell walls open, allowing sodium and potassium ions to pass through. The simulation shows that the drug's final binding site is inside the sodium gateway protein, which blocks it and prevents the signal from being transmitted.

Drugs that block sodium channels are also used to treat nerve-signal disorders such as epilepsy or heart arrhythmia. However, the current drugs target sodium channels indiscriminately throughout the body, which can lead to side effects.

Dr Corry says pharmaceutical companies are especially interested developing new drugs designed to selectively target the subtly-differing proteins in specific locations of the body, such as the heart or brain.

"Knowledge of the fine molecular detail of the drug opens up possibilities to conceive ," says Dr Corry. "Chronic pain is a big market, and an avenue I'd also like to pursue is developing antibiotics based on this approach."

add to favorites email to friend print save as pdf

Related Stories

New pain relief targets discovered

Apr 17, 2014

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Can injuries to the skin be painless?

Jun 19, 2014

When the body receives an injury to the skin, a signal is sent to the brain, which generates a sensation of pain. Teams led by Priscille Brodin in Lille and Laurent Marsollier in Angers have studied lesions in patients with ...

Recommended for you

User comments